Most bought healthcare stocks in Q4 2022

See which Healthcare stocks institutional investors increased the most in Q4 2022, measured as net growth in reported share positions from Q3 2022 into Q4 2022. Notable additions at the top of this list include ELANCO ANIMAL HEALTH INC (ELAN), HALEON PLC-ADR (HLN), FRESENIUS MEDICAL CARE-ADR (FMS), SANOFI-ADR (SNY). These rankings aggregate SEC 13F filings from all institutional investors in our database.

SymbolNameNet sharesNet valueNewAddedTrimmedSold outHolding now
ELANELANCO ANIMAL HEALTH INC28,953,448$1.04B02315
HLNHALEON PLC-ADR24,403,705$782.38M23209
FMSFRESENIUS MEDICAL CARE-ADR12,983,991$454.64M12104
SNYSANOFI-ADR8,517,779$4.10B15107
SGRYSURGERY PARTNERS INC3,679,954$165.61M01102
GSKGSK PLC-SPON ADR3,555,732$2.31B352010
OSCROSCAR HEALTH INC - CLASS A3,528,564$39.34M03004
ALHCALIGNMENT HEALTHCARE INC2,828,840$44.30M02002
TECHBIO-TECHNE CORP2,288,525$232.90M14005
NVAXNOVAVAX INC1,943,118-$766.23K11204
TMOTHERMO FISHER SCIENTIFIC INC1,884,009$3.16B449020
MRVIMARAVAI LIFESCIENCES HLDGS-A1,804,210$3.16K01102
PRMEPRIME MEDICINE INC1,640,184$30.47M20002
JNJJOHNSON & JOHNSON1,525,620$1.58B1713027
OCGNOCUGEN INC1,422,557$1.14K10102
WBAWALGREENS BOOTS ALLIANCE INC1,365,113$41.02M14208
PHGKONINKLIJKE PHILIPS NVR- NY1,343,825$12.40M02002
BAXBAXTER INTERNATIONAL INC1,187,332$15.07M03409
EWEDWARDS LIFESCIENCES CORP1,070,497$1.47M134010
VXRTVAXART INC1,015,616-$8.42K11002
AMGNAMGEN INC991,335$173.56M155013
VERVVERVE THERAPEUTICS INC972,171$84.37M11002
IOVAIOVANCE BIOTHERAPEUTICS INC903,489$5.26M02103
ACHCACADIA HEALTHCARE CO INC883,969$421.28M03104
AUPHAURINIA PHARMACEUTICALS INC821,897-$2.32M01203
CMPSCOMPASS PATHWAYS PLC808,045$9.88M01203
NRIXNURIX THERAPEUTICS INC747,132$21.81M02002
VTRSVIATRIS INC667,302$17.53M12207
CDNACAREDX INC645,396$73.60M03003
MNKDMANNKIND CORP549,099$5.94K01001
EVHEVOLENT HEALTH INC - A544,050$78.15M01001
DVAXDYNAVAX TECHNOLOGIES CORP539,244-$57.21K01011
ILMNILLUMINA INC520,752$1.04B21307
XRAYDENTSPLY SIRONA INC505,473$310.08M03114
SGMOSANGAMO THERAPEUTICS INC442,400-$55.41K01011
CLOVCLOVER HEALTH INVESTMENTS CO436,504-$5.06K02002
ALLOALLOGENE THERAPEUTICS INC432,600-$78.23K10011
PCVXVAXCYTE INC428,777$22.79K01001
CCRNCROSS COUNTRY HEALTHCARE INC427,900$11.24K01001
ACHLACHILLES THERAPEUTICS PL-ADR403,700$25301001
COYACOYA THERAPEUTICS INC392,444$1.86M10001
BMYBRISTOL-MYERS SQUIBB CO359,097$1.56B258020
ERASERASCA INC354,575$1.53K10001
THCTENET HEALTHCARE CORP353,730$38.99M12013
BNTXBIONTECH SE-ADR352,275$3.87M21003
HUMHUMANA INC341,540$112.86M14117
ALGNALIGN TECHNOLOGY INC329,872$763.73M243010
HRTXHERON THERAPEUTICS INC326,500$81610001
BGXXBRIGHT GREEN CORP309,900$14510001
ASRTASSERTIO HOLDINGS INC309,276$2.96M02002
Net change in reported shares (all institutional filers) by symbol20 symbols with net change in reported shares from all institutional filers.0.008.0M15.9M23.9M31.8MNet change in reported shares (all institutional filers)ELANHLNFMSSNYSGRYGSKOSCRALHCTECHNVAXTMOMRVIPRMEJNJOCGNWBAPHGBAXEWVXRTSymbol

Frequently asked questions about Most bought healthcare stocks in Q4 2022

  • What are the most bought Healthcare stocks in Q4 2022?

    The most bought healthcare stocks in Q4 2022 are those with the largest increase in reported share counts across institutional investors compared to Q3 2022, based on SEC 13F filings.

  • Which healthcare stocks did institutional investors added to the most in Q4 2022?

    Among filers in this sector, net additions were largest in companies such as ELANCO ANIMAL HEALTH INC (ELAN), HALEON PLC-ADR (HLN), FRESENIUS MEDICAL CARE-ADR (FMS), based on aggregated 13F data.

  • How is institutional buying calculated?

    Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q3 2022).

  • Does this include all institutional owners?

    Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.

  • Are these trades real-time?

    No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.